Literature DB >> 17434164

Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells.

Marcia L Graves1, Lixin Zhou, Gwen MacDonald, Christopher R Mueller, Calvin D Roskelley.   

Abstract

As BRCA1 expression is often suppressed in sporadic ovarian carcinoma we characterized the regulation of the 231nt proximal 'L6' fragment of the BRCA1 promoter in two human ovarian surface epithelial cell and two sporadic ovarian carcinoma cell lines. Two individual regulatory elements within L6, the 'RIBS' element and the potential 'CRE' element were each necessary, but alone not sufficient for L6 activation in all four cell lines. The latter element showed some affinity for the CREB transcription factor, but cAMP pathway stimulation failed to promote its activation. This element did, however, interact with, and was activated by, c-Jun and Fra2 which suggests that it can interact with AP1-like transcription factors and that it may act co-operatively with RIBS-binding factors to regulate BRCA1 transcription in ovarian cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434164     DOI: 10.1016/j.febslet.2007.03.072

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

2.  The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma.

Authors:  Jane A Cipollone; Marcia L Graves; Martin Köbel; Steve E Kalloger; Tak Poon; C Blake Gilks; Kelly M McNagny; Calvin D Roskelley
Journal:  Clin Exp Metastasis       Date:  2012-01-20       Impact factor: 5.150

3.  C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma.

Authors:  S Mahner; C Baasch; J Schwarz; S Hein; L Wölber; F Jänicke; K Milde-Langosch
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

4.  Differential Expression of c-fos Proto-Oncogene in Normal Oral Mucosa versus Squamous Cell Carcinoma

Authors:  Akhilesh Krishna; Madan Lal Brahma Bhatt; Vineeta Singh; Shraddha Singh; Pravin Kumar Gangwar; Uma Shankar Singh; Vijay Kumar; Divya Mehrotra
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

5.  BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.

Authors:  Leslie J Burke; Jan Sevcik; Gaetana Gambino; Emma Tudini; Eliseos J Mucaki; Ben C Shirley; Phillip Whiley; Michael T Parsons; Kim De Leeneer; Sara Gutiérrez-Enríquez; Marta Santamariña; Sandrine M Caputo; Elizabeth Santana Dos Santos; Jana Soukupova; Marketa Janatova; Petra Zemankova; Klara Lhotova; Lenka Stolarova; Mariana Borecka; Alejandro Moles-Fernández; Siranoush Manoukian; Bernardo Bonanni; Stacey L Edwards; Marinus J Blok; Thomas van Overeem Hansen; Maria Rossing; Orland Diez; Ana Vega; Kathleen B M Claes; David E Goldgar; Etienne Rouleau; Paolo Radice; Paolo Peterlongo; Peter K Rogan; Maria Caligo; Amanda B Spurdle; Melissa A Brown
Journal:  Hum Mutat       Date:  2018-09-24       Impact factor: 4.878

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.